DiaMedica Therapeutics Inc

NASDAQ:DMAC   3:59:53 PM EDT
2.40
-0.02 (-0.83%)
Earnings Announcements

Diamedica Therapeutics Announces First Quarter 2022 Results

Published: 05/04/2022 21:04 GMT
DiaMedica Therapeutics Inc (DMAC) - Diamedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results.
Diamedica Therapeutics Inc - Cash Runway Into 2024.
Diamedica Therapeutics Inc - Qtrly Basic and Diluted Net Loss per Share $0.13.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.23

More details on our Analysts Page.